Continue to vaccinate against hepatitis B.
(1) In France about 0.7% of adults carry the hepatitis B virus and more than 2000 new infections occur each year; (2) In contrast to some misleadingly alarming media reports, a new case-control study shows no link between hepatitis B vaccination and the onset of demyelinating neurological disorders in children. The risk-benefit balance of hepatitis B vaccination remains unchanged.
D000293:Adolescent; D000328:Adult; D002648:Child; D003362:Cost-Benefit Analysis; D003711:Demyelinating Diseases / Q000139:chemically induced; D005602:France / Q000453:epidemiology; D006509:Hepatitis B / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D017589:Immunization Programs; D007115:Immunization Schedule
D017325:Hepatitis B Vaccines